Current Edition

Upcoming Events



Celonic AG Appoints Soenke Brunswieck as Vice President Cell & Gene Therapy

Celonic AG, the Swiss biologics contract development and manufacturing organization, has appointed Soenke Brunswieck as Vice President Cell & Gene Therapy to establish Celonic`s new …

Continue Reading →

Achieving Large-Scale Cell and Gene Therapy Manufacturing

Initial clinical successes with cell and gene therapies have driven significant investment in these next-generation technologies by both large bio/pharma companies and start-up specialist firms …

Continue Reading →

The Swiss Biotech Association Honors Major Industry Achievements with Swiss Biotech Success Stories

On the occasion of its 20th anniversary, the Swiss Biotech Association launches Swiss Biotech Success Stories in recognition of the industry’s many accomplishments. Swiss Biotech …

Continue Reading →

Medical AI startup Synyi raises $15.7 M

Synyi will use the fund to develop medical natural language processing, medical data governance and machine learning. Venture capital firm GGV Capital has led a …

Continue Reading →

Korea to invest $33.4M in medical AI system

The ministry plans to carry out this medical artificial intelligence project over the course of three years. The South Korean government plans to invest 35.7 …

Continue Reading →

Cellmid inks deal with China’s Fukangren Bio-pharm

The deal aims to distribute Cellmid’s évolis and anti-aging hair care products in the Peoples Republic of China Australia based Cellmid has recently announced that …

Continue Reading →

Haselmeier and Common Sensing Enter Connected Injectable Medicine Collaboration

Haselmeier, a Swiss-based developer and manufacturer of innovative self-injection devices, and Common Sensing, a Cambridge-based smart injector monitoring and support solutions company, today announced a …

Continue Reading →

Q1 earnings preview: Novo, Celgene still to come

It hasn’t been the prettiest first quarter for drugmakers. Sanofi’s revenue fell, as did confidence in one of the company’s key growth drivers. Allergan discussed …

Continue Reading →

For Expensive New Drugs, Biopharma Should Make Money-Back Guarantees Mandatory

In a recent paper on “Value-Based Pricing for Drugs”, authors Anna Kaltenboeck and Peter B. Bach of the Memorial Sloan Kettering Cancer Center discuss the …

Continue Reading →

ExpreS2ion’s U.S. partner Integrated BioTherapeutics launches first ExpreS2-based research product

ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) announces that its U.S.-based partner and licensee Integrated BioTherapeutics (“IBT”) has initiated sales and marketing of its first ExpreS2-based product. The …

Continue Reading →

Saunders: All options remain on the table for Allergan

Brief: Allergan CEO Brent Saunders said Monday the Irish pharma is considering a wide range of business options, including further divestitures or a split of …

Continue Reading →

United Therapeutics nabs competing PAH drug with $216M SteadyMed buy

Brief: United Therapeutics announced Monday morning that it will acquire competitor SteadyMed for $4.46 per share in cash upfront and another $2.63 per share in …

Continue Reading →

Sparks sells regulatory fast pass to Jazz for $110M

Brief: Spark Therapeutics has sold a priority review voucher (PRV) to Jazz Pharmaceuticals for $110 million, according to a Monday disclosure. While details were scant, …

Continue Reading →

Wickham Laboratories to present at Cleanroom Technology Conference 2018

Wickham Laboratories CEO, Dr John McKenzie, will be presenting at the Cleanroom Technology Conference on the 16th May at 2:30PM, at the National Conference Centre …

Continue Reading →

Pfizer Receives CRL for Biosimilar to Roche’s Herceptin

On April 23, 2018, Pfizer announced that it received a complete response letter (CRL) from FDA in response to the biologics license application (BLA) for …

Continue Reading →

VIVUS Restructures Debt and Gains Access to New Capital

Athyrium Capital Management partners with VIVUS to support next growth phase New capital to be used to facilitate the acquisition of PANCREAZE® (pancrelipase) VIVUS, Inc. …

Continue Reading →

Chinese biopharma firm to create 400 jobs in Dundalk

WuXi Biologics will invest €325m in company’s first site outside of China A major Chinese biopharmaceutical company is to create 400 jobs with a €325 …

Continue Reading →

ADC Bio secures £1.14m investment from Downing LLP to finance innovative bioconjugation and US expansion

Funding earmarked for US market penetration and development of groundbreaking upstream bioconjugation approach ADC Biotechnology (ADC Bio), announces that it has secured £1.14 million in …

Continue Reading →

New Vertical Diffusion Cell from Copley Scientific extends options for topical semisolids and transdermal testing

Copley Scientific, a leading manufacturer of laboratory testing equipment, has introduced a new Vertical Diffusion Cell (VDC) for efficient in vitro skin permeation studies. The …

Continue Reading →

Sartorius Stedim Biotech Introduces Mini Microcarrier Bioreactor for Culturing Adherent Cells

New vessel for ambr® 250 ht system will enable cost-effective, scalable process development of vaccines in cell culture Premieres at the BPI European Summit in …

Continue Reading →